In a multi-investigator, multi-project Program Project, a number of scientific and administrative support activities are required. These are best provided in a centralized fashion rather than attempting to fragment them according to a particular project and/or investigator, especially when there are many areas of overlap. The Support Core provides such centralized approaches and is based on two components. The analytical component will provide support to the various Projects for the structural, qualitative and quantitative analysis of drugs and metabolites. Gas chromatography/mass spectrometry analyses will be performed with high sensitivity an specificity by the use of stable isotope dilution methodology in combination with electron capture negative chemical ionization. Liquid chromatography/electrospray ionization tandem mass spectrometry will be employed for the identification of drug metabolites. Alternative mass spectrometry methodology that employs electron ionization, positive chemical ionization, liquid secondary ion, matrix-assisted laser desorption is available should it be required. This component will also provide a resource for the synthesis of drug metabolites and stable isotope analogs for use as standards for stable isotope dilution assays. Analytical procedures that require conventional HPLC methodology will be developed in the Core if they are required in the individual projects. An administrative component will provide the structure to support essential but non-scientifically related activities for the individual Projects. For example, administrative coordination, fiscal management, ordering of supplies, manuscript and grant-report preparation, and the provision of common services such as duplicating, services contracts, mailing and travel support, etc. In addition, biostatistical support for all of the Projects will be provided by the Core.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM031304-18
Application #
6325866
Study Section
Project Start
2000-07-01
Project End
2001-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
18
Fiscal Year
2000
Total Cost
$267,648
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Johnson, Daniel H; Gebretsadik, Tebeb; Shintani, Ayumi et al. (2013) Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose. Br J Clin Pharmacol 75:997-1006
Kohli, Utkarsh; Pandharipande, Pratik; Muszkat, Mordechai et al. (2012) CYP2A6 genetic variation and dexmedetomidine disposition. Eur J Clin Pharmacol 68:937-42
Kohli, Utkarsh; Hahn, Maureen K; English, Brett A et al. (2011) Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans. Pharmacogenet Genomics 21:171-8
Ho, Richard H; Leake, Brenda F; Kilkenny, Dawn M et al. (2010) Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability. Pharmacogenet Genomics 20:45-57
Kohli, Utkarsh; Muszkat, Mordechai; Sofowora, Gbenga G et al. (2010) Effects of variation in the human alpha2A- and alpha2C-adrenoceptor genes on cognitive tasks and pain perception. Eur J Pain 14:154-9
Muszkat, Mordechai; Kurnik, Daniel; Sofowora, Gbenga G et al. (2010) Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype. J Hypertens 28:278-84
Muszkat, Mordechai; Bialer, Omer; Blotnick, Simcha et al. (2010) Effects of folic acid supplementation on the pharmacokinetics and anticoagulant effect of warfarin: an open-label, prospective study of long-term administration in adults. Clin Ther 32:347-56
Li, Chun; Schwarz, Ute I; Ritchie, Marylyn D et al. (2009) Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy. Blood 113:3925-30
Haas, David W; Gebretsadik, Tebeb; Mayo, Gail et al. (2009) Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americans. J Infect Dis 199:872-80
Kurnik, Daniel; Li, Chun; Sofowora, Gbenga G et al. (2008) Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade. Pharmacogenet Genomics 18:895-902

Showing the most recent 10 out of 351 publications